153 related articles for article (PubMed ID: 22793970)
1. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
de Menezes CC; Peceguini LA; Silva ED; Simões CM
Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
[TBL] [Abstract][Full Text] [Related]
2. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
Jiang Y; Bash LD; Saager L
Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
[TBL] [Abstract][Full Text] [Related]
3. Sugammadex rescue following prolonged rocuronium neuromuscular blockade with 'recurarisation' in a patient with severe renal failure.
Lobaz S; Sammut M; Damodaran A
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396837
[TBL] [Abstract][Full Text] [Related]
4. Predictive study of pharmacological reversal for residual neuromuscular blockade and postoperative pulmonary complications: a prospective, observational, cohort study.
Aragón-Benedí C; Pascual-Bellosta A; Ortega-Lucea S; Visiedo-Sánchez S; Martínez-Ubieto J;
Sci Rep; 2022 Sep; 12(1):14955. PubMed ID: 36056061
[TBL] [Abstract][Full Text] [Related]
5. Sugammadex shortens operation time and improves operation turnover efficacy in video-assisted thoracoscopic surgery.
Lin YT; Ting CK; Hsu HS
J Chin Med Assoc; 2024 Apr; 87(4):448-452. PubMed ID: 38391199
[TBL] [Abstract][Full Text] [Related]
6. Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?
Farhan H; Moreno-Duarte I; McLean D; Eikermann M
Curr Anesthesiol Rep; 2014 Dec; 4(4):290-302. PubMed ID: 25530723
[TBL] [Abstract][Full Text] [Related]
7. Use of sugammadex in prevention of post-operative urinary retention in minimally invasive hernia surgery.
Tsouknidas I; Perez S; Kunkel E; Tiko-Okoye C; Buckley ME; Gefen JY
Hernia; 2024 Apr; ():. PubMed ID: 38683482
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Different Weight Scalars to Dose Sugammadex for the Reversal of Neuromuscular Blockade in Morbidly Obese Patients: A Systematic Review.
Subramani Y; Rajarathinam M; Dabirzadeh A; Tawfic Q; Krause S; Avci Y; Nagappa M
Cureus; 2024 Mar; 16(3):e57057. PubMed ID: 38681306
[TBL] [Abstract][Full Text] [Related]
9. Selective reversal of muscle relaxation in general anesthesia: focus on sugammadex.
Brull SJ; Naguib M
Drug Des Devel Ther; 2009 Sep; 3():119-29. PubMed ID: 19920928
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Neuromuscular Monitoring Permits Early Diagnosis of Abnormal Butyrylcholinestrase: Two Case Studies Demonstrating Prevention of Awareness from Premature Awakening.
Harris EM; Funk EM; Plezia D; Elliott J; Elliott R; Pitman JS; Grant SA
AANA J; 2024 Apr; 92(2):139-143. PubMed ID: 38564210
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular monitoring: an update.
Duţu M; Ivaşcu R; Tudorache O; Morlova D; Stanca A; Negoiţă S; Corneci D
Rom J Anaesth Intensive Care; 2018 Apr; 25(1):55-60. PubMed ID: 29756064
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of monitoring and reversal habits of neuromuscular blockade by anesthesiologists in Hungary].
Fedor M; Fónyad B; Nemes R; Asztalos L; Fülesdi B; Pongrácz A
Orv Hetil; 2024 Apr; 165(15):574-583. PubMed ID: 38619890
[TBL] [Abstract][Full Text] [Related]
13. Retrospective investigation of postoperative outcome after reversal of residual neuromuscular blockade: sugammadex, neostigmine or no reversal.
Ledowski T; Falke L; Johnston F; Gillies E; Greenaway M; De Mel A; Tiong WS; Phillips M
Eur J Anaesthesiol; 2014 Aug; 31(8):423-9. PubMed ID: 24296853
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade.
Abad-Gurumeta A; Ripollés-Melchor J; Casans-Francés R; Espinosa A; Martínez-Hurtado E; Fernández-Pérez C; Ramírez JM; López-Timoneda F; Calvo-Vecino JM;
Anaesthesia; 2015 Dec; 70(12):1441-52. PubMed ID: 26558858
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
Hristovska AM; Duch P; Allingstrup M; Afshari A
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012763. PubMed ID: 28806470
[TBL] [Abstract][Full Text] [Related]
16. Reversal of neuromuscular blockade: dose determination studies with atropine and glycopyrrolate given before or in a mixture with neostigmine.
Mirakhur RK; Dundee JW; Jones CJ; Coppel DL; Clarke RS
Anesth Analg; 1981 Aug; 60(8):557-62. PubMed ID: 7196168
[TBL] [Abstract][Full Text] [Related]
17. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
[TBL] [Abstract][Full Text] [Related]
18. Sugammadex: A Review of Neuromuscular Blockade Reversal.
Keating GM
Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
[TBL] [Abstract][Full Text] [Related]
19. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.
Carron M; Baratto F; Zarantonello F; Ori C
Clinicoecon Outcomes Res; 2016; 8():43-52. PubMed ID: 26937203
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
